News
Search here results
search-total-matching72search-total-matching- Diabetes drug shows potential as disease-modifying therapy for Parkinson’s disease | UCL Queen Square Institute of Neurology - UCL – University College London
- AIM-PD: new clinical trial testing a potential disease-modifying agent in Parkinson’s disease | UCL Queen Square Institute of Neurology - UCL – University College London
Please enable JavaScript to use this page or visit this page for a non javascript version.